Clinical Report: Predictive Nomograms for Assessing Axillary Lymph Node Metastasis

Overview

This study develops predictive nomograms to assess axillary lymph node metastasis (ALNM) in early-stage breast cancer patients using preoperative ultrasound and PET/CT data. The models aim to improve clinical decision-making by identifying patients who can avoid more invasive surgical procedures.

Background

Accurate assessment of axillary lymph node involvement is critical in breast cancer management, influencing treatment decisions and patient outcomes. Traditional methods like Axillary Lymph Node Dissection (ALND) have been challenged by studies showing that less invasive techniques can be equally effective in certain patient populations. The development of reliable predictive models is essential to guide treatment strategies and minimize unnecessary surgical interventions.

Data Highlights

No numerical data available in the source material.

Key Findings

• Axillary lymph node status is a significant predictor of overall recurrence and survival in breast cancer.
• Preoperative axillary ultrasound can identify low nodal tumor burden in a substantial percentage of patients.
• Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has high specificity but variable sensitivity for detecting ALNM.
• Two predictive models were developed using clinicopathological features and imaging data to assess ALNM risk.
• These models aim to assist clinicians in determining appropriate preoperative treatment plans.

Clinical Implications

The predictive nomograms developed in this study can help clinicians identify patients who may safely avoid ALND, thereby reducing surgical morbidity. Implementing these models in clinical practice could enhance personalized treatment strategies for breast cancer patients.

Conclusion

The introduction of predictive nomograms for assessing ALNM represents a significant advancement in breast cancer management, potentially improving patient outcomes through more tailored treatment approaches.

References

1. Peking Union Medical College Hospital, Clinical Data Research, 2023 -- Predictive Nomograms for Assessing Axillary Lymph Node Metastasis
2. European Radiology — A Dual-Phase Nomogram: A Non-Invasive Resource to Aid Breast Radiologists in Clinical Decision-Making
3. European Radiology — Evaluating MRI Efficacy for Standardized Assessment of Lymph Nodes in Breast Cancer: Is Node-RADS Implementation Feasible?
4. European Radiology — Assessing Residual Axillary Disease Following Neoadjuvant Therapy in Breast Cancer Through Initial MRI and Ultrasound Evaluations
5. Identifying Risk Factors for Lymph Node Metastasis in Early Colorectal Cancer: Development of a Predictive Nomogram and Risk Evaluation
6. ASCO Special Articles
7. A Dual-Phase Nomogram: A Non-Invasive Resource to Aid Breast Radiologists in Clinical Decision-Making
8. Evaluating MRI Efficacy for Standardized Assessment of Lymph Nodes in Breast Cancer: Is Node-RADS Implementation Feasible?
9. Assessing Residual Axillary Disease Following Neoadjuvant Therapy in Breast Cancer Through Initial MRI and Ultrasound Evaluations
10. Frontiers | The role of irradiation in the management of the axilla in early breast cancer patients
11. Diagnostic performance of DCE-MRI radiomics in predicting axillary lymph node metastasis in breast cancer patients: A meta-analysis | PLOS One